Global Chronic Lower Back Pain Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Chronic Lower Back Pain Market Expected To Expand Between 2025 And 2029?

The market size for chronic lower back pain has shown consistent expansion over recent years. It is anticipated to expand from $7.72 billion in 2024 to $8.04 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.1%. This historical growth can be attributed to influences like sedentary lifestyles, manual labor and occupational risks, advancements in medical diagnosis, the progression of pain management techniques, and insights from epidemiological studies.

The market size for chronic lower back pain is projected to experience consistent expansion over the upcoming years. This market is predicted to reach “$9.63 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 4.6%. Factors contributing to this growth during the forecast period include an increase in non-pharmacological interventions, various preventive healthcare initiatives, a heightened focus on holistic treatments, advancements in regenerative medicine development, and the ongoing aging population trends. Key trends anticipated during the forecast period involve a greater emphasis on non-pharmacological interventions, a notable shift in pain management approaches, enhanced healthcare awareness and education, the expansion of telemedicine and remote monitoring, and the increasing integration of regenerative medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

What Are The Drivers Pushing New Developments In The Chronic Lower Back Pain Market?

An uptick in the occurrence of nerve instances is anticipated to fuel the expansion of the chronic lower back pain market. Nerve instances refer to particular events or scenarios where an individual exhibits bravery, courage, or resilience when facing a challenging or daunting situation. Sustained exposure to stress and discomfort can result in a phenomenon known as central sensitization. This fundamentally signifies that the nervous system becomes excessively sensitive, experiencing pain with greater intensity, even when no actual injury is present. For instance, in July 2023, as per Nature, a UK-based weekly scientific journal, the prevalence of peripheral neuropathy, which is associated with nerve damage, is reported to be 28.4% in adults aged 40 or older with diabetes and 11.8% in those without diabetes. Consequently, a rise in the frequency of nerve instances is propelling the growth of the chronic lower back pain market.

What Are The Leading Segments Analyzed In The Chronic Lower Back Pain Market?

The chronic lower back painmarket covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain

2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain

3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc; Degenerative Disc Disease; Disc Bulge; Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis; Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction; Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome; Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica; Nerve Root Compression

6) By Muscular Pain: Muscle Strain; Muscle Spasm

7) By Other Types of Pain: Myofascial Pain Syndrome; Spondylolisthesis; Osteoporosis-Related Pain

What Trends Are Redefining The Chronic Lower Back Pain Market Dynamics?

Companies operating within the chronic lower back pain market are concentrating on creating novel medications to serve their clients and maintain their competitive standing. The creation of advanced pharmaceuticals has the potential to enhance therapeutic results for individuals suffering from diverse conditions. As an example, in July 2022, Amneal Pharmaceuticals, a US-based pharmaceutical firm, introduced LYVISPAH, an oral granule formulation of baclofen (5, 10, and 20 mg), which received approval from the U.S. Food and Drug Administration (FDA) for managing spasticity linked to multiple sclerosis and other conditions affecting the spinal cord. LYVISPAH addresses and alleviates flexor spasms, along with their accompanying pain, clonus, and muscle stiffness. This medication offers adaptable, customized dosing through individual granule packets available in 5 mg, 10 mg, and 20 mg strengths, and it demonstrates bioequivalence to existing oral baclofen tablets. Individuals experiencing spinal cord injuries and other spinal cord-related ailments could also derive advantages from the use of LYVISPAH.

Which Major Firms Are Strengthening Their Position In The Chronic Lower Back Pain Industry?

Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

What Regional Growth Trends Are Shaping The Chronic Lower Back Pain Market Outlook?

North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Chronic Lower Back Pain Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp

Browse Through More Reports Similar to the Global Chronic Lower Back Pain Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795